Meropenem and piperacillin/tazobactam prescribing in critically ill patients: does augmented renal clearance affect pharmacokinetic/pharmacodynamic target attainment when extended infusions are used?
Mieke Carlier(HOGENT University of Applied Sciences and Arts), Jan J. De Waele(Ghent University Hospital), Veronique Stove(Ghent University Hospital), Jason A. Roberts(Queensland Health), Steven C. Wallis(The University of Queensland), Pieter Depuydt(Ghent University Hospital), Jeffrey Lipman(Queensland Health), Alain Verstraete(Ghent University Hospital), Eric A. J. Hoste(Ghent University Hospital), Johan Decruyenaere(Ghent University Hospital), Sofie Carrette(Ghent University Hospital)
Cited by 212
Related Papers
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
|Intensive Care Medicine|2021|5.1k
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021
|Critical Care Medicine|2021|2.8k
Intra-abdominal hypertension and the abdominal compartment syndrome: updated consensus definitions and clinical practice guidelines from the World Society of the Abdominal Compartment Syndrome
|Intensive Care Medicine|2013|1.6k
Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup
|Nature Reviews Nephrology|2017|1.5k
Results from the International Conference of Experts on Intra-abdominal Hypertension and Abdominal Compartment Syndrome. I. Definitions
|Intensive Care Medicine|2006|1.5k